Breaking Canadian GLP-1 news
GLP-1 News — Page 11
Drug approvals, price changes, generic timelines, and clinical trial results affecting GLP-1 medication costs in Canada.
Where are you in your GLP-1 journey?
Answer a few quick questions — get your cheapest path to a GLP-1 prescription, free.
Canada's Drug Agency to Decide Mounjaro Public Coverage
Provincial health plans await recommendation on Mounjaro coverage as assessment nears completion. Latest updates at GLP1Prices.ca
Novo Nordisk Forecasts Sales Slowdown from Generic Competition
Novo Nordisk officially acknowledges that generic semaglutide competition will slow Canadian sales growth as nine manufacturers prepare market entry. GLP1Prices.ca
Semaglutide Sales Hit $3.5 Billion in Canada During 2025
IQVIA Canada data reveals total 2025 semaglutide sales reached $3.5 billion across all brands as generic competition begins. Track prices at GLP1Prices.ca
Generic Semaglutide Production Begins in Canadian Facilities
Canadian pharmaceutical companies have started manufacturing generic versions of semaglutide following patent expiry. Track prices at GLP1Prices.ca
WHO Conditionally Recommends GLP-1s for Obesity Treatment 2026
World Health Organization issues conditional recommendation for GLP-1 therapies in obesity treatment, impacting Canadian regulatory decisions. GLP1Prices.ca
Felix Health Launches Generic Semaglutide Waitlist in Canada
Canadian telehealth provider Felix for Health opens waitlist for generic semaglutide as Health Canada reviews nine applications. GLP1Prices.ca
Health Canada Approves Wegovy for MASH Treatment in 2026
Health Canada issues Notice of Compliance for Wegovy semaglutide injection for MASH indication under NOC/c policy - GLP1Prices.ca
Novo Nordisk Launches Plosbrio and Poviztra Brands in Canada
Health Canada approves two new semaglutide brand names as Novo Nordisk expands product portfolio ahead of generic competition. GLP1Prices.ca
Generic Ozempic Could Cost 35% of Brand Price by End 2026
Industry experts project generic semaglutide will be priced at 35% of current Ozempic costs when it launches in Canada. Compare prices at GLP1Prices.ca
Health Canada Launches Public Generic Drug Submissions Tracker
Health Canada debuts online tracker showing status of generic drug applications under review, including semaglutide submissions. GLP1Prices.ca
Eli Lilly's Oral GLP-1 Drug Orforglipron Awaits Health Canada Review
Eli Lilly's new oral GLP-1 medication Orforglipron remains under review by Health Canada as of March 2026. Track GLP-1 drug developments at GLP1Prices.ca
Health Canada Reviews Suicide Risk with GLP-1 Medications
Health Canada examined potential risks of suicide and self-harm with GLP-1 receptor agonist medications in comprehensive safety review - GLP1Prices.ca
WHO Adds Semaglutide to Essential Medicines List 2026
World Health Organization designates semaglutide as essential medicine ahead of generic launches in Canada - GLP1Prices.ca
Eli Lilly Launches Redesigned Mounjaro KwikPen April 2026
Eli Lilly introduces updated Mounjaro KwikPen design in Canada starting April 2026, featuring enhanced injection mechanism - GLP1Prices.ca
Vimy Pharma to File Generic Semaglutide Application to Health Canada
Canadian pharmaceutical company Vimy Pharma expects to submit its generic semaglutide application to Health Canada within weeks. - GLP1Prices.ca
Health Canada Approves First GLP-1 Daily Pill Rybelsus 2026
Health Canada has approved Rybelsus as the first daily oral GLP-1 medication, marking a regulatory milestone. Compare prices at GLP1Prices.ca
Aspen Pharmacare Targets September 2026 for Generic Ozempic Launch
South African drugmaker expects Health Canada approval by Q3 2026 for generic semaglutide. Latest updates at GLP1Prices.ca
Study: Semaglutide Could Be Made for $3 Monthly in Canada
New study reveals semaglutide manufacturing costs just $3 monthly, highlighting potential for dramatic price reductions - GLP1Prices.ca
Canada Becomes Global Launching Pad for Generic Ozempic Race
With semaglutide patents expired, Canada emerges as the world's first major market for generic Ozempic competition. Compare prices at GLP1Prices.ca
Health Canada Reviews 9 Generic Semaglutide Applications for 2026
Health Canada is reviewing nine generic semaglutide applications with approvals expected Q3 2026, potentially making Canada first market for cheaper alternatives. GLP1Prices.ca
Looking for current pharmacy prices?
Compare GLP-1 prices across Canada